Discovery and Structure−Activity Relationship of Oxalylarylaminobenzoic Acids as Inhibitors of Protein Tyrosine Phosphatase 1B
Citations Over TimeTop 16% of 2003 papers
Abstract
Protein Tyrosine phosphatase 1B (PTP1B) has been implicated as a key negative regulator of both insulin and leptin signaling pathways. Using an NMR-based screening approach with 15N- and 13C-labeled PTP1B, we have identified 2,3-dimethylphenyloxalylaminobenzoic acid (1) as a general, reversible, and competitive PTPase inhibitor. Structure-based approach guided by X-ray crystallography facilitated the development of 1 into a novel series of potent and selective PTP1B inhibitors occupying both the catalytic site and a portion of the noncatalytic, second phosphotyrosine binding site. Interestingly, oral biovailability has been observed in rats for some compounds. Furthermore, we demonstrated in vivo plasma glucose lowering effects with compound 12d in ob/ob mice.
Related Papers
- → Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders(2023)113 cited
- → Reactivation of oxidized PTP1B and PTEN by thioredoxin 1(2014)102 cited
- Research and application on plant growth regulators(2008)
- Mechanism of Temperature Regulator and Application of Home Produced Regulator(2006)
- → Protein Tyrosine Pseudophosphatase Signalling Mechanisms(2022)